You have 9 free searches left this month | for more free features.

Delta-like ligand 3

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Amsterdam (Irreversible Electroporation (IRE), Nivolumab, Toll-Like

Recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Irreversible Electroporation (IRE)
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam University Medical Centre (location VUmc)
Dec 18, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Small Cell Lung Cancer Trial (Rovalpituzumab tesirine)

Completed
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • (no location specified)
Jul 28, 2021

Small Cell Lung Cancer Trial (Tarlatamab)

Available
  • Small Cell Lung Cancer
  • (no location specified)
Sep 26, 2023

Neuroendocrine Prostate Cancer Trial in Worldwide (Tarlatamab)

Recruiting
  • Neuroendocrine Prostate Cancer
  • Phoenix, Arizona
  • +19 more
Aug 11, 2022

Recurrent B Acute Lymphoblastic Leukemia, Recurrent Ph-Like Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic

Terminated
  • Recurrent B Acute Lymphoblastic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 28, 2022

B Acute Lymphoblastic Leukemia, Ph-Like Acute Lymphoblastic Leukemia Trial in Duarte (Cyclophosphamide, Cytarabine, Daunorubicin

Recruiting
  • B Acute Lymphoblastic Leukemia
  • Ph-Like Acute Lymphoblastic Leukemia
  • Duarte, California
    City of Hope Medical Center
Jul 26, 2022

Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

Terminated
  • Malignant Melanoma
  • +7 more
  • Gilbert, Arizona
  • +29 more
Sep 21, 2020

Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Neuroendocrine Carcinomas
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Sep 22, 2023

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Los Angeles, California
  • +37 more
Feb 1, 2023

Advanced or Metastatic Solid Tumors Trial in Beijing (CD40 ligand expressing MSLN-CAR T cells, Albumin-bound paclitaxel,

Recruiting
  • Advanced or Metastatic Solid Tumors
  • CD40 ligand expressing MSLN-CAR T cells
  • +2 more
  • Beijing, Beijing, China
    Kaichao Feng
Jan 19, 2023

COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

Recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901a
  • Halifax, Nova Scotia, Canada
  • +6 more
Nov 16, 2022

Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis

Not yet recruiting
  • Rheumatoid Arthritis
    • (no location specified)
    Oct 4, 2022

    Urinary Obstruction, Detrusor Underactivity Trial in Cairo (Uroflowmetry)

    Completed
    • Urinary Obstruction
    • Detrusor Underactivity
    • Uroflowmetry
    • Cairo, القاهرة, Egypt
      Ahmed Maher
    Apr 29, 2022

    Non Small Cell Lung Cancer, Lung Cancer Trial in Bronx (drug, biological, radiation)

    Recruiting
    • Non Small Cell Lung Cancer
    • Lung Cancer
    • FLT3 Ligand (CDX-301)
    • +2 more
    • Bronx, New York
      Albert Einstein College of Medicine
    Jul 18, 2022

    Titanium Modular Revision Hip System, With Review of Metal Ion

    Not yet recruiting
    • Hip Surgery
    • x-ray
    • (no location specified)
    Sep 11, 2023

    Small-cell Lung Cancer Trial in United States (HPN328)

    Recruiting
    • Small-cell Lung Cancer
    • Aurora, Colorado
    • +9 more
    Jan 11, 2022

    Acromegaly Trial in Los Angeles (Pegvisomant, Octreotide LAR, Lanreotide)

    Terminated
    • Acromegaly
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Dec 12, 2022

    Insomnia Trial in San Francisco (Defined CBD, Placebo)

    Active, not recruiting
    • Insomnia
    • Defined CBD
    • Placebo
    • San Francisco, California
      Defined Research
    Jul 26, 2022

    Sleep Deprivation, Cognitive Impairment Trial (Sleep deprivatin, Sleep recovery)

    Not yet recruiting
    • Sleep Deprivation
    • Cognitive Impairment
    • Sleep deprivatin
    • Sleep recovery
    • (no location specified)
    Jun 20, 2023

    Glioma Trial (BI 764532)

    Not yet recruiting
    • Glioma
    • BI 764532
    • (no location specified)
    Jun 15, 2023

    APDS Trial in Netherlands, United States (Leniolisib)

    Not yet recruiting
    • APDS
    • Los Angeles, California
    • +4 more
    Jan 12, 2023

    Schizophrenia, Mental Disorders, Psychotic Disorders Trial in West Haven (THC and Iomazenil, Placebo (control))

    Completed
    • Schizophrenia
    • +2 more
    • THC and Iomazenil
    • Placebo (control)
    • West Haven, Connecticut
      VA Connecticut Healthcare System
    Dec 2, 2022

    Testing and Epidemiology of Delta Hepatitis

    Not yet recruiting
    • Chronic Hepatitis D Infection With Hepatitis B
      • Los Angeles, California
        Asian Pacific Liver Center
      Dec 20, 2021